These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11334)

  • 41. Visual effects of pilocarpine in glaucoma comparative study of administration by eyedrops or by ocular therapeutic systems.
    Brown HS; Meltzer G; Merrill RC; Fisher M; Ferré C; Place VA
    Arch Ophthalmol; 1976 Oct; 94(10):1716-9. PubMed ID: 973819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of fibrin film as a carrier for drug delivery: a long-acting delivery system for pilocarpine into the eye.
    Miyazaki S; Ishii K; Takada M
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3405-7. PubMed ID: 7172339
    [No Abstract]   [Full Text] [Related]  

  • 43. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation.
    Choi SM; Lee YG; Seo MJ; Kang KK; Ahn BO; Yoo M
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):209-14. PubMed ID: 19456255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].
    Wei J; He HL; Zheng CL; Zhu JB
    Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of tear film dynamics on quality of vision.
    Koh S; Tung CI; Inoue Y; Jhanji V
    Br J Ophthalmol; 2018 Dec; 102(12):1615-1620. PubMed ID: 29907632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oily vehicle on ocular pilocarpine concentration.
    Salminen L
    Acta Ophthalmol (Copenh); 1979 Aug; 57(4):633-6. PubMed ID: 525286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.
    Singh SR; Carreiro ST; Chu J; Prasanna G; Niesman MR; Collette Iii WW; Younis HS; Sartnurak S; Gukasyan HJ
    J Pharm Pharmacol; 2009 Jun; 61(6):733-42. PubMed ID: 19505363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tear Film Pharmacokinetics and Systemic Absorption Following Topical Administration of 1% Prednisolone Acetate Ophthalmic Suspension in Dogs.
    Sebbag L; Kirner NS; Wulf LW; Mochel JP
    Front Vet Sci; 2020; 7():571350. PubMed ID: 33195562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitation of pilocarpine flux enhancement across isolated rabbit cornea by hydrogel polymer lenses.
    Krohn DL; Breitfeller JM
    Invest Ophthalmol; 1975 Feb; 14(2):152-5. PubMed ID: 1112641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo evaluation of submicron emulsions with pilocarpine: the effect of pH and chemical form of the drug.
    Sznitowska M; Janicki S; Zurowska-Pryczkowska K; Mackiewicz J
    J Microencapsul; 2001; 18(2):173-81. PubMed ID: 11253934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ocular pharmacokinetics of pilocarpine micron emulsion in rabbits].
    Xu Y; Chen Z; Song J; Zhang J; Xie L
    Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):446-8. PubMed ID: 11835858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of reactivity and viscosity on the action of ophthalmic drops containing cocaine and pilocarpine].
    Pankowska B; Felczak J
    Klin Oczna; 1975 Jul; 45(7):795-800. PubMed ID: 240062
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
    Mun Y; Kwon JW; Oh JY
    BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.
    Lee VH; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):673-84. PubMed ID: 458563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aqueous humor pilocarpine and timolol levels after instillation of the single drug or in combination.
    Ellis PP; Wu PY; Riegel M
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):520-2. PubMed ID: 2001926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antiglaucoma ophthalmic agents with prolonged action based on macromolecular excipients. 1. In vitro studies].
    Pergande G; Keipert S
    Pharmazie; 1990 Jul; 45(8):582-6. PubMed ID: 2080203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tear fluid-eye drops compatibility assessment using surface tension.
    Hotujac Grgurević M; Juretić M; Hafner A; Lovrić J; Pepić I
    Drug Dev Ind Pharm; 2017 Feb; 43(2):275-282. PubMed ID: 27645109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topically applied pilocarpine. Human pupillary response as a function of drop size.
    File RR; Patton TF
    Arch Ophthalmol; 1980 Jan; 98(1):112-5. PubMed ID: 7352857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.